loading
Precedente Chiudi:
$70.76
Aprire:
$70.63
Volume 24 ore:
80,217
Relative Volume:
0.26
Capitalizzazione di mercato:
$1.49B
Reddito:
$486.82M
Utile/perdita netta:
$18.78M
Rapporto P/E:
86.13
EPS:
0.82
Flusso di cassa netto:
$100.45M
1 W Prestazione:
+3.70%
1M Prestazione:
+4.86%
6M Prestazione:
+21.17%
1 anno Prestazione:
+7.42%
Intervallo 1D:
Value
$69.29
$71.16
Intervallo di 1 settimana:
Value
$68.19
$72.57
Portata 52W:
Value
$52.50
$72.57

Ani Pharmaceuticals Inc Stock (ANIP) Company Profile

Name
Nome
Ani Pharmaceuticals Inc
Name
Telefono
(218) 634-3500
Name
Indirizzo
210 MAIN STREET WEST, BAUDETTE, MN
Name
Dipendente
897
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-08
Name
Ultimi documenti SEC
Name
ANIP's Discussions on Twitter

Confronta ANIP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
ANIP
Ani Pharmaceuticals Inc
70.71 1.49B 486.82M 18.78M 100.45M 0.82
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
155.29 66.90B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.28 48.25B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.16 47.13B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.41 16.06B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
297.88 13.15B 2.76B 1.11B 898.10M 22.77

Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-14 Iniziato Jefferies Buy
2025-03-12 Iniziato JP Morgan Overweight
2024-12-11 Iniziato Leerink Partners Outperform
2024-10-11 Iniziato Piper Sandler Overweight
2024-03-15 Iniziato CapitalOne Overweight
2023-08-22 Reiterato H.C. Wainwright Buy
2023-03-01 Iniziato Guggenheim Buy
2022-09-07 Iniziato H.C. Wainwright Buy
2021-11-02 Iniziato Truist Buy
2020-05-07 Downgrade Cantor Fitzgerald Overweight → Neutral
2019-09-12 Iniziato Guggenheim Buy
2019-05-10 Downgrade Raymond James Strong Buy → Outperform
2017-10-16 Reiterato Canaccord Genuity Buy
2017-07-31 Iniziato Canaccord Genuity Buy
2017-02-22 Downgrade ROTH Capital Buy → Neutral
2016-06-23 Iniziato Raymond James Strong Buy
2016-05-24 Downgrade Standpoint Research Buy → Hold
2015-11-13 Iniziato Standpoint Research Buy
2015-09-28 Aggiornamento ROTH Capital Neutral → Buy
2015-08-05 Reiterato Oppenheimer Outperform
2015-08-04 Reiterato ROTH Capital Neutral
2015-07-31 Reiterato Oppenheimer Outperform
2015-07-15 Reiterato ROTH Capital Neutral
2015-06-23 Reiterato Oppenheimer Outperform
2015-05-18 Reiterato ROTH Capital Neutral
2015-05-06 Reiterato Oppenheimer Outperform
2015-04-10 Downgrade ROTH Capital Buy → Neutral
2015-02-26 Reiterato ROTH Capital Buy
2015-02-18 Reiterato Oppenheimer Outperform
Mostra tutto

Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie

pulisher
Apr 29, 2025

The 4.0% return this week takes ANI Pharmaceuticals' (NASDAQ:ANIP) shareholders three-year gains to 135% - simplywall.st

Apr 29, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 24, 2025

Zacks.com featured highlights include Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI - TradingView

Apr 24, 2025
pulisher
Apr 23, 2025

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year? - Yahoo Finance

Apr 23, 2025
pulisher
Apr 23, 2025

Zacks.com featured highlights include ANI Pharmaceuticals, Heritage Insurance, Avista and Exelon - Yahoo Finance

Apr 23, 2025
pulisher
Apr 23, 2025

Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue - TradingView

Apr 23, 2025
pulisher
Apr 21, 2025

Truist raises ANI Pharmaceuticals target to $65, maintains hold By Investing.com - Investing.com India

Apr 21, 2025
pulisher
Apr 21, 2025

Truist Lifts Price Target on ANI Pharmaceuticals to $65 From $62, Keeps Hold Rating - marketscreener.com

Apr 21, 2025
pulisher
Apr 17, 2025

ANI Pharmaceuticals, Inc. (ANIP) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance

Apr 17, 2025
pulisher
Apr 15, 2025

ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance

Apr 15, 2025
pulisher
Apr 15, 2025

ANI Pharmaceuticals (ANIP): Buy, Sell, Or Hold Post Q4 Earnings? - Barchart.com

Apr 15, 2025
pulisher
Apr 14, 2025

Ani Pharmaceuticals Sr. VP sells $27,583 in stock By Investing.com - Investing.com Canada

Apr 14, 2025
pulisher
Apr 13, 2025

StockNews.com Downgrades ANI Pharmaceuticals (NASDAQ:ANIP) to Sell - MarketBeat

Apr 13, 2025
pulisher
Apr 11, 2025

Deep Dive Into ANI Pharmaceuticals Stock: Analyst Perspectives (6 Ratings) - Benzinga

Apr 11, 2025
pulisher
Apr 11, 2025

ANI Pharmaceuticals (ANIP) Set for Potential Earnings Beat - GuruFocus

Apr 11, 2025
pulisher
Apr 09, 2025

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET - GlobeNewswire

Apr 09, 2025
pulisher
Apr 09, 2025

ANI Pharmaceuticals Reveals Q1 2025 Earnings Date: Key Executive Insights Coming May 9 - Stock Titan

Apr 09, 2025
pulisher
Apr 08, 2025

Zacks.com featured highlights ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE - Yahoo Finance

Apr 08, 2025
pulisher
Apr 07, 2025

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Apr 07, 2025
pulisher
Apr 07, 2025

Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO - TradingView

Apr 07, 2025
pulisher
Apr 03, 2025

ANI Pharmaceuticals at RBC Conference: Strategic Growth in Rare Diseases By Investing.com - Investing.com Canada

Apr 03, 2025
pulisher
Apr 03, 2025

Is The Options Market Predicting A Spike In ANI Pharmaceuticals (ANIP) Stock? - Barchart.com

Apr 03, 2025
pulisher
Apr 03, 2025

Is the Options Market Predicting a Spike in ANI Pharmaceuticals (ANIP) Stock? - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

ANI Pharmaceuticals To Present At RBC Capital Markets Conference; Webcast At 7:45 AM ET - Nasdaq

Apr 03, 2025
pulisher
Apr 02, 2025

Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree - Yahoo Finance

Apr 02, 2025
pulisher
Mar 31, 2025

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference - GlobeNewswire

Mar 31, 2025
pulisher
Mar 28, 2025

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Fly 25% But Investors Aren't Buying For Growth - simplywall.st

Mar 28, 2025
pulisher
Mar 25, 2025

5 Top-Ranked Mid-Cap Stocks to Buy for a Stellar Portfolio - TradingView

Mar 25, 2025
pulisher
Mar 24, 2025

Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance

Mar 24, 2025
pulisher
Mar 24, 2025

Should You Buy ANI Pharmaceuticals (ANIP) After Golden Cross? - Zacks Investment Research

Mar 24, 2025
pulisher
Mar 21, 2025

Is Corcept Therapeutics (CORT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Mar 21, 2025
pulisher
Mar 20, 2025

Alimera Sciences announces change to SmPC allowing all United Kingdom (Great Britain and Northern Ireland) qualified ophthalmic healthcare professionals experienced in intravitreal injections to administer ILUVIEN - PharmiWeb.com

Mar 20, 2025
pulisher
Mar 19, 2025

Ultragenyx (RARE) Aligns With FDA on Phase III Neuro Study Plans - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

ANI Pharmaceuticals Launches Kionex Suspension For Electrolyte Imbalance Management: Key Trend Transforming... - WhaTech

Mar 19, 2025
pulisher
Mar 19, 2025

ANI Pharmaceuticals launches generic Nitazoxanide Tablets By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Ani Pharmaceuticals Launches Nitazoxanide Tablets for Treating Diarrhea -March 19, 2025 at 09:33 am EDT - MarketScreener

Mar 19, 2025
pulisher
Mar 19, 2025

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets - GlobeNewswire

Mar 19, 2025
pulisher
Mar 19, 2025

ANI Pharmaceuticals launches generic Nitazoxanide Tablets - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

ANI Pharmaceuticals Announces The Launch Of Nitazoxanide Tablets -March 19, 2025 at 06:51 am EDT - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Generic Drug Alert: ANI Pharmaceuticals Takes On $36M Market With New Alinia Alternative - StockTitan

Mar 19, 2025
pulisher
Mar 19, 2025

ANI Pharmaceuticals settles royalty obligation for $17.25 million By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

ANI Pharmaceuticals Eliminates Royalty Obligation On ILUVIEN And YUTIQ - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

ANI Pharmaceuticals settles royalty obligation for $17.25 million - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

ANI Pharma buys Iluvien and Yutiq royalties (ANIP:NASDAQ) - Seeking Alpha

Mar 18, 2025
pulisher
Mar 18, 2025

ANI Pharma buys royalties linked to Iluvien and Yutiq - MSN

Mar 18, 2025
pulisher
Mar 18, 2025

ANI Pharmaceuticals Completes Buyout of Royalty Obligation for Iluvien, Yutiq -March 18, 2025 at 08:20 am EDT - Marketscreener.com

Mar 18, 2025

Ani Pharmaceuticals Inc Azioni (ANIP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$28.74
price up icon 2.69%
$102.05
price down icon 1.58%
$8.33
price up icon 0.36%
$107.57
price down icon 0.29%
drug_manufacturers_specialty_generic RDY
$13.97
price down icon 0.22%
$315.50
price up icon 5.53%
Capitalizzazione:     |  Volume (24 ore):